drugset / Trial / NCT01787188

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

NCT01787188

Phase 3 Completed 403 enrolled Iroko Pharmaceuticals, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Meloxicam \[Test\] Capsules are safe and effective for the treatment of osteoarthritis pain of the knee or hip.

Timeline

Start
2013-02
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule 5 mg
Subject Meloxicam Small molecule 10 mg

Indications